Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial

• Exploring possibilities towards PeRsonalIsed MEdicine in Rheumatoid Arthritis (PRIMERA): tailored modifications to standard treat-to-target management—a multicentre, randomised, open-label trial

  2026 RMD Open article Medicine Rheumatoid Arthritis Research and Therapies Open access

  0

  citations
• Successful discontinuation of oral glucocorticoids after short-term bridging therapy in patients with newly diagnosed rheumatoid arthritis

  2026 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access

  1

  citations
• Development and validation of a model to predict the disease activity score: towards a remote treat-to-target approach for rheumatoid arthritis

  2025 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access

  2

  citations
• Sustained DMARD-free remission in subgroups of patients with rheumatoid arthritis: an analysis of two prospective cohorts with early arthritis

  2024 The Lancet Rheumatology article Medicine Rheumatoid Arthritis Research and Therapies Open access

  6

  citations
• The prognostic value of IgA anti-citrullinated protein antibodies and rheumatoid factor in an early arthritis population with a treat-to-target approach

  2024 Immunologic Research article Medicine Rheumatoid Arthritis Research and Therapies Open access

  6

  citations
• Responsiveness and sensitivity of PROMs to change in disease activity status in early and established rheumatoid arthritis

  2024 Lara D. Veeken article Medicine Rheumatoid Arthritis Research and Therapies Open access

  3

  citations
• Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time?

  2023 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access

  18

  citations
• Genome‐wide Association Study of Methotrexate‐Induced Liver Injury in Rheumatoid Arthritis Patients

  2023 Clinical Pharmacology & Therapeutics article Pharmacology, Toxicology and Pharmaceutics Drug-Induced Hepatotoxicity and Protection Open access

  9

  citations
• Rheumatoid Arthritis

  2023 Springer eBooks book-chapter Medicine Rheumatoid Arthritis Research and Therapies Open access

  0

  citations
• Machine learning identifies a profile of inadequate responder to methotrexate in rheumatoid arthritis

  2022 Lara D. Veeken article Medicine Rheumatoid Arthritis Research and Therapies Open access

  33

  citations
• Factors that influence biological survival in rheumatoid arthritis: results of a real-world academic cohort from the Netherlands

  2021 Clinical Rheumatology article Medicine Rheumatoid Arthritis Research and Therapies Open access

  16

  citations
• Two-year cost effectiveness between two gradual tapering strategies in rheumatoid arthritis: cost-utility analysis of the TARA trial

  2020 Annals of the Rheumatic Diseases article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access

  21

  citations
• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

  2020 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access cited by 5 patents

  2,714

  citations
• Dose reduction and withdrawal strategy for TNF-inhibitors in psoriatic arthritis and axial spondyloarthritis: design of a pragmatic open-label, randomised, non-inferiority trial

  2020 Trials article Medicine Spondyloarthritis Studies and Treatments Open access

  21

  citations

14 results